These final results, together with a preceding report showing that a small-molecule ACKR3 agonist CCX771 reveals anxiolytic-like habits in mice,2 guidance the idea of focusing on ACKR3 as a novel strategy to modulate the opioid method, which could open new therapeutic avenues for opioid-related